We are pleased to announce that the meeting “The biology and management of bradykinin-mediated disorders" will be held on Monday 5 November 2012 at the RSM.
"The biology and management of bradykinin-mediated disorders" is a conference focused on the regulation of the formation of bradykinin and its mechanism of action in human disease
and covers the latest developments in the management of angioedema and allergic disease by targeting the bradykinin pathway.
We will be awarding 50 bursary places to those of a student or trainee grade. To apply for these places please email
[log in to unmask] with your name, address, telephone number, grade and institution. Places will be awarded on a first come first serve basis.
Don't miss your opportunity to be involved!
Programme includes:
·Management of angioedema
·Regulation of bradykinin formation
·Bradykinin receptors and their regulation
·Novel drugs and unusual angioedema
·Bradykinin: The latest wheeze in allergic airway disease?
·Bradykinin and mast cells
·Bradykinin and infections
·Mechanisms of bradykinin formation in angioedema
Confirmed speakers:
·Dr Allen Kaplan, Medical University of South Carolina
·Professor Heiko Herwald, Lund University
·Dr Andrew Walls, University of Southampton
·Dr Paul Turner, Institute of Child Health, UCL and St Mary's Hospital/Imperial College London
·Dr Hilary Longhurst, Barts and the London Hospitals
·Professor Fredrik Leeb-Lundberg, Lund University
·Dr Thomas Renné, Karolinska Institute
·Professor Konrad Bork, Universitaets-Hautklinik, Mainz, Germany
Prices:
Early bird prices apply until 24 September 2012
The Royal Society of Medicine, 1 Wimpole Street, London W1G 0AE, UK.
Tel: +44 (0) 20 7290 2987 | Registered Charity: 206219 | www.rsm.ac.uk
To unsubscribe from all RSM emails, please
click here.
***************** Important Notice - Disclaimer ******************
This email is from the Royal Society of Medicine, Registered Charity No:- 206219 This email and any attachments may contain confidential information and/or copyright material. This email is intended for the use of the addressee only. Any unauthorised use may be unlawful. If you receive this email by mistake, please advise the sender immediately by using the reply facility in your email software and then delete the message. Email sent to the RSM may be monitored in line with current legislation and good practice.
**************************************************************************
______________________________________________________________________
This email has been scanned by the Symantec Email Security.cloud service.
For more information please visit http://www.symanteccloud.com
______________________________________________________________________
